Document is current
Any future updates will be listed below
-
Authors
Peterson, Avery B. https://orcid.org/0000-0001-6531-5431
Wilderman, Scott J.
Blakkisrud, Johan
Wong, Ka Kit
Frey, Kirk A.
Dewaraja, Yuni K.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA240706)
National Cancer Institute (R01CA289631)
- License Information
-
More Information
Article History
Received: 18 June 2024
Accepted: 8 November 2025
First Online: 4 December 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the University of Michigan (HUM00212260/ HUM00224502). Written informed consent was obtained from participants who were prospectively recruited to receive post-therapy imaging. Some data was accessed retrospectively in accordance with the IRB-approved protocols.
: Written informed consent was obtained from participants according to the IRB-approved protocols, which included consent to publish.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: YKD is a consultant for GE Healthcare's MIM Software, RayzeBio, and MERIT CRO and receives institutional research funding from GE Healthcare and Novartis. The other authors have no relevant financial or non-financial interests to disclose.
